CSK and type 1 diabetes mellitus: This missense polymorphism changes arginine (R) to tryptophan (W) at position 620, impairing its interaction with the tyrosine kinase Csk, which enhances PTPN22 activation and decreases interleukin-2 production, thus increasing susceptibility to type I diabetes [32].